May 5th 2022
Mental wellbeing is more of a focus than ever before in cancer care, and while treatments continue to get better, there is still a long road ahead, according to Patrick Dempsey.
April 22nd 2022
An expert discusses the side effects patients with kidney cancer may experience from immunotherapy and tyrosine kinase inhibitor treatment, and how more research is needed in to ensure patients experience less side effects.
April 14th 2022
Over the past 20 years, advancements in the lung cancer space have led to a drastic paradigm shift in how patients are now treated, ultimately leading to substantial improvements in survival and patient quality of life.
April 5th 2022
Monumental treatment advancements over the past two decades have given patients with thyroid cancer the ability to live longer and better lives, according to an expert from Cleveland Clinic’s Taussig Cancer Institute. However, more work is needed to find curative treatments.
March 29th 2022
Twenty years of updates in technology, techniques and available medications has provided more hope for patients with colorectal cancer, with more advances on the horizon.
March 24th 2022
Over the last 20 years, head and neck cancer treatment moved away from aggressive treatments for all patients to a more personalized approach — improving both outcomes and quality of life for patients with the disease.
March 21st 2022
In honor of CURE®’s 20th anniversary, we spoke with experts on how the past 20 years have revolutionized multiple myeloma treatment.
March 10th 2022
Aesthetic appearances, according to an expert at the UCSF, are often important for patients following the surgical treatment of cancer. Advancements in this space over the past 20 years have allowed many to patients to look as normal as possible.
March 7th 2022
Increased resources and technological advances have allowed cancer survivors experiencing psychological side effects to seek help that might not have been available to them 20 years ago.
February 11th 2022
A blood cancer specialist discusses how the development of tyrosine kinase inhibitors in the 1990s to treat chronic myelogenous leukemia drove major oncology advancements over the next three decades.
February 9th 2022
The executive director of the National LGBT Cancer Network discussed the past two decades of positive change in LGBTQ cancer care and highlighted what more still needs to be done.
February 1st 2022
A woman with metastatic breast cancer reflects on her pre-cancer life 20 years ago and how her perspective on the disease has shifted as she’s reached a level of acceptance and hope for the future.
January 24th 2022
When Joseph Heisler was diagnosed with von Hippel-Lindau disease 30 years ago, there was hardly any information on the condition. Fast forward three decades, there is an FDA-approved drug and a handbook of information available in two languages.